Russell Investments Group’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14M	Buy	63,246 +15,989	+34%	+$321K	﹤0.01%	2151
2025 Q4	$1.11M	Buy	47,257 +43,936	+1,323%	+$953K	﹤0.01%	2177
2025 Q3	$66.3K	Buy	3,321 +3,125	+1,594%	+$56.1K	﹤0.01%	3167
2025 Q2	$2.69K	Buy	+196	New	+$1.88K	﹤0.01%	3548
2024 Q4	–	Sell	-253	Closed	-$3.21K	–	3801
2024 Q3	$3.21K	Hold	253	–	–	﹤0.01%	3301
2024 Q2	$4.25K	Hold	253	–	–	﹤0.01%	3250
2024 Q1	$3.79K	Hold	253	–	–	﹤0.01%	2979
2023 Q4	$3.79K	Hold	253	–	–	﹤0.01%	2935
2023 Q3	$3.54K	Hold	253	–	–	﹤0.01%	3192
2023 Q2	$2.62K	Hold	253	–	–	﹤0.01%	3202
2023 Q1	$2.34K	Buy	+253	New	+$2.33K	﹤0.01%	2999
2022 Q3	–	Sell	-1,962	Closed	-$16K	–	2980
2022 Q2	$16K	Hold	1,962	–	–	﹤0.01%	2815
2022 Q1	$17K	Hold	1,962	–	–	﹤0.01%	2687
2021 Q4	$18K	Sell	1,962 -55,035	-97%	-$776K	﹤0.01%	2955
2021 Q3	$958K	Buy	56,997 +121	+0.2%	+$1.92K	﹤0.01%	2207
2021 Q2	$867K	Buy	56,876 +22,923	+68%	+$414K	﹤0.01%	2379
2021 Q1	$660K	Sell	33,953 -23,268	-41%	-$494K	﹤0.01%	2404
2020 Q4	$1.03M	Buy	+57,221	New	+$1.2M	﹤0.01%	2103
2018 Q4	–	Sell	-2,523	Closed	-$119K	–	3038
2018 Q3	$119K	Buy	+2,523	New	+$117K	﹤0.01%	2736